Article
Genetic causes of clopidogrel nonresponsiveness: which ones really count?
Pharmacotherapy - 1 Mar 2010
Momary Kathryn M, Dorsch Michael P, Bates Eric R
Abstract excerpt
Clopidogrel decreases the morbidity and mortality associated with several cardiovascular diseases. However, clopidogrel is a prodrug that needs to be metabolized to the active thiol metabolite by the cytochrome P450 (CYP) system. This activation is a source of significant interindividual variability in clopidogrel responsiveness. Drug interactions with and genetic variation in CYP3A4, CYP3A5, and CYP2C19 enzymes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
